287 related articles for article (PubMed ID: 22611192)
21. Phosphorylation at serine 331 is required for Aurora B activation.
Petsalaki E; Akoumianaki T; Black EJ; Gillespie DA; Zachos G
J Cell Biol; 2011 Oct; 195(3):449-66. PubMed ID: 22024163
[TBL] [Abstract][Full Text] [Related]
22. p53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of Aurora kinases.
Marxer M; Ma HT; Man WY; Poon RY
Oncogene; 2014 Jul; 33(27):3550-60. PubMed ID: 23955083
[TBL] [Abstract][Full Text] [Related]
23. Direct association with inner centromere protein (INCENP) activates the novel chromosomal passenger protein, Aurora-C.
Li X; Sakashita G; Matsuzaki H; Sugimoto K; Kimura K; Hanaoka F; Taniguchi H; Furukawa K; Urano T
J Biol Chem; 2004 Nov; 279(45):47201-11. PubMed ID: 15316025
[TBL] [Abstract][Full Text] [Related]
24. The transcription factor YY1 is a novel substrate for Aurora B kinase at G2/M transition of the cell cycle.
Kassardjian A; Rizkallah R; Riman S; Renfro SH; Alexander KE; Hurt MM
PLoS One; 2012; 7(11):e50645. PubMed ID: 23226345
[TBL] [Abstract][Full Text] [Related]
25. Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity.
Song SJ; Song MS; Kim SJ; Kim SY; Kwon SH; Kim JG; Calvisi DF; Kang D; Lim DS
Cancer Res; 2009 Mar; 69(6):2314-23. PubMed ID: 19276349
[TBL] [Abstract][Full Text] [Related]
26. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
[TBL] [Abstract][Full Text] [Related]
27. Aurora-C and Aurora-B share phosphorylation and regulation of CENP-A and Borealin during mitosis.
Slattery SD; Moore RV; Brinkley BR; Hall RM
Cell Cycle; 2008 Mar; 7(6):787-95. PubMed ID: 18239465
[TBL] [Abstract][Full Text] [Related]
28. Regulation of APC/CCdc20 activity by RASSF1A-APC/CCdc20 circuitry.
Chow C; Wong N; Pagano M; Lun SW; Nakayama KI; Nakayama K; Lo KW
Oncogene; 2012 Apr; 31(15):1975-87. PubMed ID: 21874044
[TBL] [Abstract][Full Text] [Related]
29. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.
Liu Q; Kaneko S; Yang L; Feldman RI; Nicosia SV; Chen J; Cheng JQ
J Biol Chem; 2004 Dec; 279(50):52175-82. PubMed ID: 15469940
[TBL] [Abstract][Full Text] [Related]
30. The Deubiquitinating Enzyme USP14 Regulates Leukemic Chemotherapy Drugs-Induced Cell Apoptosis by Suppressing Ubiquitination of Aurora Kinase B.
Song C; Ma R; Yang X; Pang S
Cell Physiol Biochem; 2017; 42(3):965-973. PubMed ID: 28662510
[TBL] [Abstract][Full Text] [Related]
31. Co-regulation of the antagonistic RepoMan:Aurora-B pair in proliferating cells.
Manzione MG; Rombouts J; Steklov M; Pasquali L; Sablina A; Gelens L; Qian J; Bollen M
Mol Biol Cell; 2020 Mar; 31(6):419-438. PubMed ID: 31967936
[TBL] [Abstract][Full Text] [Related]
32. Aurora B: a new prognostic marker and therapeutic target in cancer.
Portella G; Passaro C; Chieffi P
Curr Med Chem; 2011; 18(4):482-96. PubMed ID: 21143115
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of action of the Aurora kinase inhibitor CCT129202 and in vivo quantification of biological activity.
Chan F; Sun C; Perumal M; Nguyen QD; Bavetsias V; McDonald E; Martins V; Wilsher NE; Raynaud FI; Valenti M; Eccles S; Te Poele R; Workman P; Aboagye EO; Linardopoulos S
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3147-57. PubMed ID: 18089709
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of NuMA by Aurora-A kinase in PC-3 prostate cancer cells affects proliferation, survival, and interphase NuMA localization.
Toughiri R; Li X; Du Q; Bieberich CJ
J Cell Biochem; 2013 Apr; 114(4):823-30. PubMed ID: 23097092
[TBL] [Abstract][Full Text] [Related]
35. A positive feedback loop involving Haspin and Aurora B promotes CPC accumulation at centromeres in mitosis.
Wang F; Ulyanova NP; van der Waal MS; Patnaik D; Lens SM; Higgins JM
Curr Biol; 2011 Jun; 21(12):1061-9. PubMed ID: 21658950
[TBL] [Abstract][Full Text] [Related]
36. Aurora-B mediated ATM serine 1403 phosphorylation is required for mitotic ATM activation and the spindle checkpoint.
Yang C; Tang X; Guo X; Niikura Y; Kitagawa K; Cui K; Wong ST; Fu L; Xu B
Mol Cell; 2011 Nov; 44(4):597-608. PubMed ID: 22099307
[TBL] [Abstract][Full Text] [Related]
37. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases.
Crosio C; Fimia GM; Loury R; Kimura M; Okano Y; Zhou H; Sen S; Allis CD; Sassone-Corsi P
Mol Cell Biol; 2002 Feb; 22(3):874-85. PubMed ID: 11784863
[TBL] [Abstract][Full Text] [Related]
38. Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis.
Wang F; Dai J; Daum JR; Niedzialkowska E; Banerjee B; Stukenberg PT; Gorbsky GJ; Higgins JM
Science; 2010 Oct; 330(6001):231-5. PubMed ID: 20705812
[TBL] [Abstract][Full Text] [Related]
39. An Aurora kinase inhibitor, AMG900, inhibits glioblastoma cell proliferation by disrupting mitotic progression.
Ryu J; Pyo J; Lee CW; Kim JE
Cancer Med; 2018 Nov; 7(11):5589-5603. PubMed ID: 30221846
[TBL] [Abstract][Full Text] [Related]
40. Aurora-B kinase inhibitors for cancer chemotherapy.
Yeung SC; Gully C; Lee MH
Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
